Keywords: Hovione, Financial results FY to march 2010
Hovione's sales grow 15% for FY to March 2010
Article | 29 July 2010
Portuguese drugmaker Hovione announced yesterday that the consolidated sales for the fiscal year ended March 31, 2010, amounted to $144 million, representing an ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
